Skip to main content
Livermore
Livermore
ZHEN

Future Fund LLC

SEC CIK
0001911970
Latest filing
Aug 12, 2026

The latest 13F from Future Fund LLC covers Q2 2026 (filed Aug 12, 2026): 118 long positions worth $348.8M. The top 10 holdings make up 21.1% of the portfolio, and the largest is Halozyme Therapeutics, Inc. (HALO) at 3.2%. Livermore has 19 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
10
Est. +$35.8M
Added
93
Est. +$44.5M
Reduced
15
Est. −$20.9M
Sold out
19
Est. −$31.7M

Top 5 holdings

Share of this quarter's portfolio value

  1. HALOHalozyme Therapeutics, Inc.
    3.2%$11.1MHistory
  2. GHGuardant Health, Inc.
    2.8%$9.64MHistory
  3. NVDANVIDIA Corp
    2.2%$7.81MHistory
  4. BWXTBWX Technologies, Inc.
    2.2%$7.75MHistory
  5. CIENCiena Corp
    2.0%$7.14MHistory

Share of portfolio

Top 5 holdings and the other 113 positions, by share of portfolio value

  1. HALO3.2%
  2. GH2.8%
  3. NVDA2.2%
  4. BWXT2.2%
  5. CIEN2.0%
  6. Other 113 positions87.5%

Biggest buys

New and added positions, by estimated amount bought

  1. CIENCiena Corp
    +$7.14MNewHistory
  2. LFUSLittelfuse Inc
    +$6.12MNewHistory
  3. AXONAxon Enterprise, Inc.
    +$5.51MNewHistory
  4. SITMSITIME Corp
    +$4.78MNewHistory
  5. HALOHalozyme Therapeutics, Inc.
    +$3.67MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. CIENCiena Corp
    +2.05 pp0.0% → 2.0%History
  2. LFUSLittelfuse Inc
    +1.75 pp0.0% → 1.8%History
  3. AXONAxon Enterprise, Inc.
    +1.58 pp0.0% → 1.6%History
  4. SITMSITIME Corp
    +1.37 pp0.0% → 1.4%History
  5. GHGuardant Health, Inc.
    +1.25 pp1.5% → 2.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. FTITechnipFMC plc
    −$5.35MSold outHistory
  2. ONTOOnto Innovation Inc.
    −$5.00MReducedHistory
  3. TIGOMillicom International Cellular SA
    −$4.65MReducedHistory
  4. RMBSRambus Inc
    −$2.96MSold outHistory
  5. COHRCoherent Corp.
    −$2.93MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. FTITechnipFMC plc
    −1.88 pp1.9% → 0.0%History
  2. TIGOMillicom International Cellular SA
    −1.36 pp2.4% → 1.0%History
  3. RMBSRambus Inc
    −1.04 pp1.0% → 0.0%History
  4. WGSGeneDx Holdings Corp.
    −0.99 pp1.0% → 0.0%History
  5. CAKECheesecake Factory Inc
    −0.92 pp0.9% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$348.8M
+$64.4M (+22.6%) vs. prior quarter
Positions
118
−9 vs. prior quarter
Top 10 concentration
21.1%
Top 10 as share of value
Turnover
16.6%
Q2 2026, one quarter
Average holding period
5.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

19 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $348.8M (Q2 2026)

Q4 2021: $100.7MQ1 2022: $82.4MQ2 2022: $44.0MQ3 2022: $49.7MQ4 2022: $23.8MQ1 2023: $30.6MQ2 2023: $10.5MQ3 2023: $36.0MQ4 2023: $36.3MQ1 2024: $12.3MQ2 2024: $39.8MQ3 2024: $34.6MQ4 2024: $35.0MQ1 2025: $77.8MQ2 2025: $224.0MQ3 2025: $283.4MQ4 2025: $283.6MQ1 2026: $284.4MQ2 2026: $348.8M
Q4 2021Q2 2026
13F filings of Future Fund LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 12, 2026118$348.8MHALOGHNVDAvs. Q1 2026SEC
Q1 2026May 6, 2026127$284.4MTIGOBWXTHALOvs. Q4 2025SEC
Q4 2025Feb 10, 2026143$283.6MiShares Russell Mid-Cap Growth ETFiShares S&P Small-Cap 600 Growth ETFHALOvs. Q3 2025SEC
Q3 2025Nov 12, 2025170$283.4MiShares Russell Mid-Cap Growth ETFiShares S&P Small-Cap 600 Growth ETFiShares Russell 2000 Growth ETFvs. Q2 2025SEC
Q2 2025Aug 7, 2025170$224.0MiShares Russell Mid-Cap Growth ETFiShares S&P Small-Cap 600 Growth ETFNVDAvs. Q1 2025SEC
Q1 2025May 15, 202580$77.8MNVDAGOOGLMETAvs. Q4 2024SEC
Q4 2024Feb 7, 202531$35.0MNVDAGOOGLNFLXvs. Q3 2024SEC
Q3 2024Nov 5, 202430$34.6MNVDAGOOGLCRMvs. Q2 2024SEC
Q2 2024Aug 14, 202433$39.8MGOOGLLLYNVDAvs. Q1 2024SEC
Q1 2024May 15, 202428$12.3MGOOGLNVDALLYvs. Q4 2023SEC
Q4 2023Feb 14, 202429$36.3MTSLAGOOGLNVDAvs. Q3 2023SEC
Q3 2023Nov 13, 202329$36.0MTSLAGOOGLAAPLvs. Q2 2023SEC
Q2 2023Aug 14, 202327$10.5MGOOGLTSLAPWRvs. Q1 2023SEC
Q1 2023May 15, 202322$30.6MTSLAGOOGLCMGvs. Q4 2022SEC
Q4 2022Feb 13, 202322$23.8MTSLACROXGOOGLvs. Q3 2022SEC
Q3 2022Nov 18, 202219$49.7MTSLAGOOGLHOGvs. Q2 2022SEC
Q2 2022Aug 15, 202222$44.0MTSLAGOOGLCELHvs. Q1 2022SEC
Q1 2022May 17, 202229$82.4MTSLAGOOGLSPLKvs. Q4 2021SEC
Q4 2021Feb 18, 202236$100.7MTSLAGOOGLTSPH–SEC